Lithuania vs Other small states: Prevalence of hypertension
Lithuania
48.0%
in 2019
Other small states
36.8%
in 2019
Lithuania rank
11th
Other small states rank
13th
Prevalence of hypertension over time
- Lithuania
- Other small states
How they compare
Lithuania currently reports 48.0% against 36.8% in Other small states, a difference of 11.2%.
That makes Lithuania's figure about 1.3 times Other small states's.
Across all 30 years both countries report, Lithuania has been ahead every year.
Lithuania ranks 11th and Other small states ranks 13th of 192 countries.
Lithuania has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Lithuania | Other small states | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 54.7% | 38.9% | 15.7% | Lithuania |
| 2000s | 52.2% | 39.0% | 13.2% | Lithuania |
| 2010s | 49.5% | 37.9% | 11.7% | Lithuania |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher prevalence of hypertension, Lithuania or Other small states?
- Lithuania, at 48.0% against 36.8% in Other small states as of 2019.
- What is the difference in prevalence of hypertension between Lithuania and Other small states?
- 11.2%, with Lithuania ahead.
- How many years of comparable data are there for Lithuania and Other small states?
- 30 years are reported by both, from 1990 to 2019.
- How do Lithuania and Other small states rank globally for prevalence of hypertension?
- Lithuania ranks 11th and Other small states ranks 13th of 192 countries.
- Where does this data come from?
- World Health Organization's Global Health Observatory Data Repository, published as Prevalence of hypertension (% of adults ages 30-79). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Prevalence of hypertension is the percentage of adults ages 30-79 with hypertension (defined as having systolic blood pressure =140 mmHg, diastolic blood pressure =90 mmHg, or taking medication for hypertension). The data is age-standardized.